9 unchanged sentences
S-1/A 1/21/20 4.2
−Removed: 4.3 Description of Arcutis Biotherapeutics’ Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.
−Removed: 10-K 3/19/20 4.3
−Removed: 10.1† Supply and Manufacturing Agreement, dated September 15, 2021, between DPT Laboratories, Ltd.
−Removed: and the Registrant .
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
ARCUTIS BIOTHERAPEUTICS, INC.
−Removed: November 04, 2021 By:
+Added: May 05, 2022 By:
/s/ Todd Franklin Watanabe
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 04, 2021 By:
+Added: May 05, 2022 By:
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.